Ruxience (rituximab-pvvr) Injection, 500 mg/50 mL Single-Dose Vial
Ruxience is a biosimilar to rituximab, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 500 mg of rituximab-pvvr in 50 mL. It is indicated for the treatment of certain autoimmune conditions and malignancies, including non-Hodgkin's lymphoma and rheumatoid arthritis.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Ruxience is a biosimilar to rituximab, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 500 mg of rituximab-pvvr in 50 mL. It is indicated for the treatment of certain autoimmune conditions and malignancies, including non-Hodgkin's lymphoma and rheumatoid arthritis.
1 vendor
